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Abstract
Objective:  Maternal  depression  and  anxiety  have  been  found  to  negatively  affect  fetal  and
neonatal growth.  However,  the  independent  effects  of  maternal  depression  and  anxiety  on
fetal-neonatal  growth  outcomes  and  trajectories  remain  unclear.  This  study  aimed  to  analyze
simultaneously  the effects  of  maternal  prenatal  depression  and  anxiety  on  (1) neonatal  growth
outcomes, and  (2),  on fetal-neonatal  growth  trajectories,  from  the  2nd  trimester  of  pregnancy
to childbirth.
Methods:  A sample  of  172 women  was  recruited  and  completed  self-reported  measures  of
depression  and  anxiety  during  the  2nd  and 3rd  trimesters  of  pregnancy,  and  at childbirth.  Fetal
and neonatal  biometrical  data  were  collected  from  clinical  reports  at the  same  assessment
moments.
Results: Neonates  of  prenatally  anxious  mothers  showed  lower  weight  (p  =  0.006),  length
(p =  0.025),  and  ponderal  index  (p  = 0.049)  at  birth  than  neonates  of  prenatally  non-anxious
mothers. Moreover,  fetuses-neonates  of  high-anxiety  mothers  showed  a  lower  increase  of  weight
from the 2nd  trimester  of pregnancy  to  childbirth  than  fetuses-neonates  of  low-anxiety  moth-
ers (p  < 0.001).  Considering  maternal  depression  and  anxiety  simultaneously,  only  the  effect  of
maternal  anxiety  was  found  on  these  markers  of  fetal-neonatal  growth  outcomes  and  trajecto-
ries.
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J Pediatr (Rio J). 2017. http://dx.doi.org/10.1016/j.jped.2016.11.005
∗ Corresponding author.
E-mail: tmpinto@psi.uminho.pt (T.M. Pinto).
http://dx.doi.org/10.1016/j.jped.2016.11.005
0021-7557/© 2017 Sociedade Brasileira de Pediatria. Published by  Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
JPED-474; No. of  Pages 8
Documento descargado de http://jped.elsevier.es el 05/03/2017. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.
ARTICLE IN PRESS+Model
2  Pinto  TM  et al.
Conclusion:  This  study  demonstrates  the  independent  longitudinal  effect  of  maternal  anxiety  on
major markers  of  fetal-neonatal  growth  outcomes  and  trajectories,  simultaneously  considering
the effect  of  maternal  depression  and  anxiety.
©  2017  Sociedade  Brasileira  de Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is an  open
access article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Resumo
Objetivo:  Foi  constatado  que  a  depressão  e ansiedade  materna  afetam  negativamente  o cresci-
mento fetal  e  neonatal.  Contudo,  o  efeito  independente  da  depressão  e ansiedade  materna
sobre os  resultados  e  as  trajetórias  de  crescimento  fetal  e  neonatal  continua  incerto.  Este  estudo
visou  analisar  simultaneamente  o  efeito  da depressão  e ansiedade  materna  pré-natal  (1) sobre
os resultados  de  crescimento  neonatal  e  (2)  sobre  as  trajetórias  do crescimento  fetal-neonatal
a partir  do 2◦ trimestre  de  gravidez  até o  parto.
Métodos:  Uma  amostra  de 172  mulheres  foi  recrutada  e  as  mesmas  relataram  graus  de
depressão  e  ansiedade  no 2◦ e  3◦ trimestre  de gravidez  e  parto.  Os  dados  biométricos  fetais  e
neonatais  foram  coletados  dos  prontuários  clínicos  nas mesmas  ondas  de  avaliac¸ão.
Resultados:  Os  neonatos  de mães  ansiosas  no  período  pré-natal  mostraram  menor  peso
(p =  0.006),  comprimento  (p  =  0.025)  e  índice  ponderal  (p  =  0.049)  no nascimento  que  os neonatos
de mães  não  ansiosas  no período  pré-natal.  Além  disso,  os  neonatos  de mães  muito  ansiosas
mostraram  um  menor  aumento  de  peso  do  2◦ trimestre  de gravidez  até  o  parto  que  os  fetos-
neonatos de  mães  pouco  ansiosas  (p  <  0.001).  Considerando  simultaneamente  a  depressão  e a
ansiedade maternal,  apenas  o  efeito  da  ansiedade  materna  foi  constatado  nesses  marcadores
de resultados  e trajetórias  de  crescimento  fetal-neonatal.
Conclusão:  Este  estudo  demonstra  o efeito  longitudinal  independente  da  ansiedade  materna
sobre os principais  marcadores  de resultados  e  trajetórias  de crescimento  fetal-neonatal,  con-
siderando simultaneamente  o efeito  da  depressão  e  ansiedade  materna.
© 2017  Sociedade  Brasileira  de Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um artigo
Open Access  sob  uma  licenc¸a  CC BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
Introduction
The  short-term  consequences  of  prenatal  depression  and
anxiety  on  pregnant  women’s  physical  health include  obstet-
ric  complications  and  physical  symptoms,  which  are both
associated  with  lower  fetal and neonatal  growth  and  lower
autonomic  nervous  system  (ANS)  maturation.1,2 Depression
and  anxiety  share  a  common  genetic  pathway,  and often
appear  simultaneously,  making  it difficult  to  assess  their
independent  effects.  Thus,  when  analyzing  the effects  of
maternal  depression  and anxiety,  it may  be  important  to
consider  both  simultaneously,  in  order  to control  their
mutual  effects  and  to better  identify  the independent  effect
of  each  one.3
Various  studies  have  found  similar  effects  of maternal
prenatal  depression  and  anxiety  on  fetal  growth,  behavior,
and  ANS  maturation.  Both  fetuses  of  depressed  and  anx-
ious  mothers  were  found  to  present  lower  estimated  weight
and  higher  total  fetal activity.4--6 In addition,  studies  have
found  that  both  fetuses  of  depressed  or  anxious  mothers
show  higher  heart  rate  reactivity  compared  with  fetuses  of
non-depressed  or  non-anxious  mothers.2,7--10
Moreover,  studies  also  have  found  similar  effects  of
maternal  prenatal  depression  and  anxiety  on  neona-
tal  growth,  behavioral,  and maturation  outcomes.  Both
neonates  of  prenatally  depressed  or  anxious  mothers  pre-
sented  higher  risk  of  premature  birth  and  low  weight,
both  major  problems  of  infant  health.11--13 Neonates  of
depressed  or  anxious  mothers  were  found  to  present  dis-
organized  sleep  patterns  and frequent  changes  of mood.2
Lower  maturation  was  also  found  in neonates  of  prenatally
depressed  or  anxious  mothers,  including  less  vagal  tonus,
and  lower  neurobehavioral  maturity.2,11,13,14 Furthermore,
both  neonates  of  prenatally  depressed  or  anxious  moth-
ers were  found  to  show  higher  levels  of  cortisol  and  lower
levels  of  dopamine  and  serotonin  when compared  with  hor-
monal  levels  of neonates  of  prenatally  non-depressed  or
non-anxious  mothers.15 Other  studies  also  reported  that
both  infants  of  prenatally  depressed  or  anxious  mothers
present  increased  admission  rates  to  the  neonatal  care  unit
and  growth  retardation  during  the first  year  of  life.16,17
Few  studies  have  simultaneously  considered  mater-
nal  depression  and  anxiety  when  analyzing  the effect
on  fetal/neonatal  growth  and  behavior.  When  simul-
taneously  considering  maternal  depression  and  anxiety,
studies  only found  an independent  effect  of  maternal
anxiety  on  fetal/neonatal  growth  and behavior.18--20 One
cross-sectional  study  only found  an  effect  of  maternal
anxiety  on fetal  growth  and behavior  (fetuses  of anx-
ious  mothers  presented  lower  estimated  weight  and  higher
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activity  at  mid-pregnancy).18 Additionally,  two  longitudi-
nal  studies  only  found  an  effect  of  maternal  anxiety  on
fetal-neonatal  growth  trajectories  (higher  maternal  anxi-
ety  during  pregnancy  was  associated  with  lower  increase
of  fetal-neonatal  weight).19,20 However,  these  studies  only
included  one  assessment  of maternal  prenatal  depression
and  anxiety  (during  pregnancy)  when  analyzing  their  effect
on  fetal/neonatal  growth,  not  addressing  the  longitudinal
effect  of  both  maternal  depression  and  anxiety.
Both  maternal  depression  and  anxiety  were  found  to
negatively  affect  fetal  and neonatal  growth.  Despite  these
effects  having  been  widely  documented  in literature,  the
independent  effects  of  maternal  depression  and  anxiety
on  fetal-neonatal  growth  outcomes  and  trajectories  remain
unclear.  Moreover,  there  is  a lack  of  studies  that  have  simul-
taneously  addressed  the independent  longitudinal  effect  of
maternal  depression  and  anxiety  on fetal-neonatal  growth
trajectories.  This  study  aimed  to  simultaneously  analyze  the
effect  of  maternal  prenatal  depression  and  anxiety  on  (1)
neonatal  outcomes,  and (2),  on  fetal-neonatal  growth  tra-
jectories,  from  the 2nd  trimester  of  pregnancy  to  childbirth.
Method
Participants
The  sample  was  comprised  of 172 mothers  recruited  at a
public  health  service  in Northern  Portugal  during  the  1st
trimester  of pregnancy  (8--14  gestational  weeks).  Inclusion
criteria  were:  able  to  read  and  write  in Portuguese;  resident
in  Portugal  for  at least  one  year; at  most  14  weeks  pregnant;
and,  singleton  gestations  without  medical  and/or  obstetric
complications.  From  the  172  mothers  who  completed  the
1st  moment  of  assessment,  88.4%  (n = 152)  completed  all  the
three  moments  of  assessment.
Procedures
This  study  was  conducted  in accordance  with  the  Declara-
tion  of  Helsinki  and was  previously  approved  by the  ethics
committees  of  all  institutions  involved.  Women  willing  to
participate  provided  written  informed  consent,  after an
explanation  of  the  study  aims  and  procedures.  This  study
had  a  longitudinal  design  with  three  assessment  moments:
2nd  trimester  of pregnancy  (20--24  gestational  weeks),
3rd  trimester  of  pregnancy  (30--34 gestational  weeks),
and  childbirth  (1--3 postnatal  days).  Mothers  repeatedly
completed  a  measure  of  depression  and anxiety.  Obstet-
ric  records  and  fetal  and  neonatal  biometrical  data  were
collected  from  clinical  reports  during  the 2nd  and  3rd
trimester  of pregnancy,  and at childbirth.  To  avoid  poten-
tial  errors  associated  with  estimated  age,  gestational  age
was  estimated  based  on  mothers’  last  menstrual  period  and
confirmed  using  ultrasound  measurements.
Measures
Socio-demographic  and  obstetric  information  was  obtained
using  a  socio-demographic  questionnaire.  To  assess  mater-
nal  depression,  the  Portuguese  version  of  the Edinburgh
Postnatal  Depression  Scale  (EPDS)21,22 was  used.  The  EPDS  is
a  self-reported  scale  composed  of  ten  items  on  a four-point
Likert  scale.  A cutoff  point  of  10  was  suggested  to  screen
for  depression  in Portuguese  women.22 Several  studies  have
used this  scale  in women  during  pregnancy  and the postna-
tal  period.18--20 The  Portuguese  version  of  the  EPDS  showed
good  internal  consistency  in women  during  pregnancy  and
the  postnatal  period  (˛  =  0.85).18,22 In  the  present  study,
Cronbach’s  alpha  coefficients  ranged  from  0.84  to  0.85.
To  assess  maternal  anxiety,  the Portuguese  version  of
the  State-Trait  Anxiety  Inventory  (STAI)23,24 was  used.  The
STAI  is  composed  of  two  subscales:  one to  assess  anxiety  as
an  emotional  state  (STAI-S)  and  another  to  assess  the  trait
of anxiety  (STAI-T),  each  containing  20  items scored  on  a
four-point  Likert  scale.  A  cutoff  point  of 45  was  suggested
to  screen  for  high  anxiety  in Portuguese  women.24 Several
studies  have  used  this measure  in women  during  pregnancy
and  the postnatal  period.18,19 The  Portuguese  version  of the
STAI-S  showed  good  internal  consistency  in women  during
pregnancy  and  the postnatal  period  (˛  ranged from  0.87  to
0.93).24 In the  present  sample,  Cronbach’s  alpha  coefficients
of STAI-S  ranged from  0.89  to  0.93.
To  assess  fetal  growth,  estimated  fetal  weight  (measured
in  grams)  was  obtained  from  the obstetric  ultrasounds  at the
2nd  and 3rd  trimesters  of  pregnancy.  These  measures  were
obtained  following  a standard  clinical  measurement  proto-
col  by  an  obstetrician  from  the  research  team.  Estimated
fetal  weight  was  calculated  using  the Hadlock  formula.25
To  assess  neonatal  growth outcomes,  neonatal  weight,
length  (measured  in centimeters),  ponderal  index
(100  × [weight/length3]),  and  gestational  age  at  birth
(measured  in weeks)  were  collected  from  medical reports.
These  measures  were  suggested  by  previous  research  as
major  markers  of  fetal-neonatal  growth  and outcomes.18--20
Data  analysis  strategy
To  simultaneously  analyze  the  effect  of  maternal  prenatal
depression  and  anxiety  on  neonatal  outcomes,  a  two-way
multivariate  analysis  of  covariance  (MANCOVA)  was  per-
formed.  In  the model,  maternal  prenatal  depression  and
anxiety  (mean  of  the scores  at the  2nd  and 3rd  trimester
of  pregnancy;  coded  as 0  =  EPDS  < 10  and  1  =  EPDS  ≥  10  for
depression;  0 = STAI-S  <  45  and  1  =  STAI-S  ≥  45  for  anxiety)
were  included  as  independent  variables  and  neonatal  growth
outcomes  (weight,  length,  ponderal  index,  and  gestational
age  at birth)  as  dependent  variables.  The  mother’s  weight
before  pregnancy  and tobacco  and  coffee  consumption
during  pregnancy  were  included  as  covariates.  The  two-
way  MANCOVA  was  performed  using  SPSS  (IBM  Corp;  SPSS
Statistics  for  Windows,  version  23.0.  USA).  The  effect  size,
measured  as  partial  eta  squared  (p2),  was  presented  for
the  two-way  MANCOVA  results.
To  simultaneously  analyze  the  effects  of  maternal
depression  and  anxiety  on  fetal-neonatal  growth  trajec-
tories,  growth  curve models  (GCM)  were  estimated  using
multilevel  modeling.  Time  0  was  defined  as  the date  of
the  first  assessment  during  the  2nd  trimester  of pregnancy
(baseline)  and  the  time  variable  was  scored  in  weeks  since
the  baseline  until  the  childbirth.  Scale  scores  for  fetal-
neonatal  weight,  maternal  depressive  (EPDS  scores),  and
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anxiety  symptoms  (STAI-S  scores)  were  examined  at each
assessment  moment.  Fixed  effects  for  maternal  depressive
and  anxiety  symptoms  (time-varying  effects  centered  on
their  grand  means)  were  included  in  the model.  Two  dif-
ferent  models  were  performed  (the  unconditional  model
and  the  model  with  predictors).  The  mother’s  weight  before
pregnancy  and  tobacco  and coffee  consumption  during preg-
nancy  were  included  as  covariates.  Significant  interactions
were  interpreted  and  graphed  using  one standard  deviation
above  and  below the grand  mean  of the predictor  varia-
bles  as  high  and low values.  A deviance  difference  test  was
performed  between  the unconditional  model  and the model
with  predictors  to  examine  model  fit  improvements.  GCMs
were  performed  in a pairwise  person-period  dataset  using
SPSS  version  23.0  (SPSS  Inc.,  United  States). The  resulting
data  consisted  of  516 potential  observations  (172  partici-
pants  by  three  time  points).  The  effect  size  r was  estimated
for  all  significant  effects.
Results
Nearly  all  the mothers  were  Portuguese  (92.1%),  white
(94.8%),  married  or  cohabiting  (86.8%),  and living  with  a
partner  (86.2%).  More  than  half  were  aged  between  18
and  29 years  old  (M = 27.69,  SD  =  5.82),  were  of medium-
low  or  low  socio-economic  level (62.0%),  were  employed
(67.1%),  and  had between  nine  and  12  years  of  education
(54.5%).  Additionally,  more  than  a  half  of  the  mothers  were
primiparous  (52.1%)  and  had  an eutocic  delivery  (with  or
without  epidural;  56.3%).  The  majority  reported  no  tobacco
consumption  during  pregnancy  (83.8%),  more  than  a half
reported  no  coffee  consumption  (70.7%),  and  all  reported
no  alcohol  and drug  consumption  during pregnancy.
More  than  a half  of  the  neonates  were  males  (56.3%)  and
born  with  a length  ≥50  cm (63.5%).  The  majority  were  not
reanimated  at birth  (94.0%),  born  with  a weight  between
2500  and  4199  g (91.0%),  a  ponderal  index  ≥2.50  (81.2%),  a
gestational  age  at birth of  ≥37  weeks  (95.8%),  and  had an
Apgar  score  between  7  and  10  at  the  1st (92.6%)  and  5th
minute  (98.8%),  respectively  (Table 1).
No  associations  and  differences  were  found  between  the
mothers  that  completed  and  did not  complete  the three
assessment  moments,  regarding  mothers’  and  neonates’
variables.
Additionally,  no  associations  and  differences  were  found
between  the  mothers  that  completed  and  did  not  complete
the  three  assessment  moments  in  all  the study  variables  at
each  moment  of assessment.
Descriptive  statistics  for  all  study  variables  at each
assessment  were  performed  (Table 2).  Significant  associa-
tions  were  found  among  the study  variables  at the  baseline
(r  ranging  from  −0.289,  p <  0.05,  to  0.652,  p  <  0.001).  No
association  was  found  between  fetal  weight  and maternal
depressive  symptoms  at the  baseline.
The  effects  of maternal  prenatal  depression  and
anxiety on  neonatal  growth  outcomes
The  two-way  MANCOVA  revealed  significant  multivariate
effects  of  maternal  prenatal  anxiety  on  neonatal  growth
outcomes,  Wilk’s  Lambda  =  0.91,  F(4,142)  =  3.29,  p  =  0.013,
Table  1 Mothers’  obstetric  and socio-demographic  charac-
teristics and  neonates’  biometric  data.
Mothers
n  = 172  (%)
Age  (years) 15--17 4.8
18--29 51.5
30--41 43.7
Socio-economic
level
High  15.7
Medium-high  4.7
Medium  17.6
Medium-low  22.2
Low  39.8
Professional
status
Employed  67.1
Unemployed  25.7
Household/student  7.2
Education  (in
years)
<9  27.5
9--12  54.5
>12  18.0
Parity Primiparous  52.1
Multiparous  47.9
Delivery  type Eutocic  56.3
Dystocic  43.7
Tobacco
consumption
Yes  16.2
No  83.8
Coffee
consumption
Yes  29.3
No  70.7
Neonates
n  = 168  (%)
Sex Male  56.3
Female  43.7
Reanimation Yes  6.0
No 94.0
Weight  (g) <2500  6.6
2500--4199 91.0
≥4200 2.4
Length  (cm) <50  63.5
≥50  36.5
Ponderal  Index <2.50  18.8
≥2.50  81.2
Gestational  age
at birth
(weeks)
<37  4.2
≥37 95.8
p2 =  0.09.  Results  revealed  significant  univariate  effects
of  prenatal  maternal  anxiety  on  neonatal  weight,  neona-
tal  length,  and  on  neonatal  ponderal  index.  Neonates  of
prenatally  anxious  mothers  showed  lower  weight,  length,
and  ponderal  index  at birth than  neonates  of  prenatally
non-anxious  mothers.  No  significant  univariate  effects  of
prenatal  maternal  anxiety  were  found on  neonatal  gesta-
tional  age at  birth  (Table 3).
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Table  2  Descriptive  statistics  of  study  variables  across  time.
Pregnancy
2nd  trimester 3rd  trimester  Childbirth
Depression  n =  172 (%)  n  =  165  (%)  n  =  160  (%)
Non-depressed  (EPDS  <  10) 75.6  75.8  76.3
Depressed (EPDS  ≥  10)  24.4  24.2  23.7
Anxiety n =  170 (%)  n  =  164  (%)  n  =  160  (%)
Non-anxious  (STAI-S  < 45)  84.1  76.8  79.9
Anxious (STAI-S  ≥ 45)  15.9  23.2  23.1
M SD M  SD  M  SD
Fetal/neonatal  weight  417.51  120.66 1722.36  397.96  3177.64  479.97
Depressive symptoms  6.78  4.38  6.48  4.39  6.17  4.84
Anxious symptoms 36.48 8.98  37.77  10.28  36.66 10.32
M, mean; SD, standard deviation; EPDS, Edinburgh Postnatal Depression Scale; STAI-S, state anxiety inventory.
No  significant  multivariate  effects  of  prenatal  maternal
depression  were  found  on  neonatal  growth  outcomes,  Wilk’s
Lambda  =  0.95,  F(4,142)  = 1.92,  p  =  0.110,  p2 =  0.05.
The  effects of  maternal  depression  and anxiety  on
fetal-neonatal  growth  trajectories,  from  the  2nd
trimester of pregnancy  to childbirth
The  main  effects  over  time  were  found  on  fetal-neonatal
weight,  b =  96.71,  SE  = 1.71,  95%  CI = [93.33,  100.08],
p  < 0.001,  effect  size  r = 0.95.  From  the 2nd  trimester  of
pregnancy  to  childbirth,  fetal-neonatal  weight  increased,  on
average,  97  g  per  week.  Additionally,  interaction  effects  of
anxiety  symptoms  and  time  were  found,  b = 2.65,  SE  = 0.10,
95%  CI  =  [2.45,  2.86],  p <  0.001,  effect  size  r =  0.86.  Fetuses-
neonates  of  high-anxiety  mothers  showed  a lower  increase
of  weight  from  the  2nd  trimester  of  pregnancy  to  childbirth
than  fetuses-neonates  of  low-anxiety  mothers  (Fig.  1).  No
main  effects  of  maternal  anxiety  symptoms  were  found on
fetal  weight.
No  main  effects  of  maternal  depressive  symptoms
were  found  on  fetal  weight.  Likewise,  no  effects  of
the  interaction  between  maternal  depressive  symptoms
and  time,  and  no  effects  of  the interaction  between
maternal  depressive  symptoms,  maternal  anxiety  symp-
toms,  and  time  were  found.  Intercept  and  random  effects
(intercept  +  time;  residuals)  were  statistically  significant
(all  values  of  p < 0.001).  The  deviance  difference  test
showed  that  the  model with  predictors  (maternal  depres-
sive  and  anxiety  symptoms)  provided  a  good  fit  to  the data,

2(5)  =  138.87,  p <  0.001.
Discussion
Simultaneously  considering  the effect  of  maternal  prena-
tal  depression  and anxiety,  a  significant  independent  effect
of  prenatal  maternal  anxiety  was  found on major markers
of  neonatal  growth  outcomes.  Neonates  of  prenatally  anx-
ious  mothers  showed  lower  weight,  length,  and ponderal
index  at  birth than  neonates  of  prenatally  non-anxious  moth-
ers.  These  results  are  consistent  with  prior  research  that
found  that  neonates  of  anxious  mothers  were  born  with
lower  weight,  length,  and  ponderal  index.2 Moreover,  simul-
taneously  considering  maternal  depression  and  anxiety,  a
significant  interaction  effect  of  maternal  anxiety  symptoms
and  time  was  found on  a major  marker  of  fetal-neonatal
growth.  This  result  suggested  an  effect  of maternal  anxiety
symptoms  on  fetal-neonatal  weight  trajectories,  from  the
2nd  trimester  of pregnancy  to  childbirth.  Fetuses-neonates
of  anxious  mothers  showed  a  lower  increase  of weight,  from
the  2nd trimester  of  pregnancy  to  childbirth,  than  fetuses-
neonates  of  non-anxious  mothers.  These  findings  suggest
that  maternal  anxiety  negatively  affect  this major  marker
of  normative  fetal-neonatal  growth  trajectories,  from  the
prenatal  period  to  childbirth,  even  when simultaneously
considering  the effect  of  maternal  depression.  This  result
is  consistent  with  previous  research  that  found  a  lower
increase  of  weight  in  fetuses-neonates  of anxious  mothers
than  in fetuses-neonates  of  non-anxious  mothers  from  preg-
nancy  to childbirth.18,19
Several  underlying  mechanisms  have  been  suggested  to
explain  the effect  of maternal  anxiety  on fetal-neonatal
growth.  Epigenetic  mechanisms  have  been  proposed  as
possible  mediators  of  the prenatal  anxiety  effect  on  fetal-
neonatal  growth.  Studies  have  suggested  that  prenatal
anxiety  can  permanently  alter  fetal  physiology,  namely
hyperactivation  of  the  fetal  hypothalamic  pituitary  adrenal
(HPA)  axis.26,27 Literature  has  also  suggested  the  mother’s
HPA  hyperactivation  as  a mediator  of  the  maternal  prenatal
anxiety  effect  on  fetal-neonatal  growth.28 Prenatal  anxi-
ety  could  be a  stressor  for  pregnant  women,  stimulating
the  HPA-axis  to  produce  higher  levels  of  glucocorticoids.
Maternal  glucocorticoids  can  be transduced  to  the  fetus
by  transplacental  transport  and  by  stress-induced  release
of  placental  hormones  into  fetal circulation.  Increased
fetal  cortisol  contributes  to  the maturation  of  organ
systems  required  for  extra-uterine  survival.  However,  exces-
sive  levels  of  feto-placental  glucocorticoid  may  result  in
intrauterine  growth restriction.28 Further,  maternal  prena-
tal  anxiety  has  been  associated  with  generally  reduced  food
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Table  3  The  effect  of  maternal  prenatal  depression  and  anxiety  on neonatal  growth  outcomes.
Prenatal  depression  Prenatal  anxiety
Non-depressed  Depressed  Non-anxious  Anxious
(n = 114)  (n  = 39)  (n  =  122)  (n  =  28)
Growth
outcomes
M  SD  M  SD  F  df  p2 M SD M  SD  F  df  p2
Weight  3213.74  465.79  3088.21  517.33  2.85  1,145  0.02  3360.21  397.12  3142.34  495.21  12.36b 1145  0.08
Length 48.66  2.19  48.18  2.35  1.24  1,145  0.01  48.96 2.09  48.43 2.27  5.11a 1145  0.03
Ponderal index  2.79  0.36  2.74  0.20  1.99  1,145  0.02  2.86  0.27  2.75  0.34  3.96a 1145  0.03
Gestational age
at birth
38.89  1.29  38.57  1.50  0.85  1,145  0.00  38.81 1.17  38.80 1.40  0.26  1145  0.00
M, mean; SD, standard deviation.
Note: Mother’s weight before pregnancy and tobacco and coffee consumption during pregnancy were included as covariates.
a p < 0.05.
b p < 0.01.
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Figure  1  Estimated  weight  trajectories  for  fetuses-neonates  of  high-anxiety  and low-anxiety  mothers.
intake  and  low  intake  of  essential  vitamins  and fatty  acids
(e.g.,  folic  acid,  vitamin  B12).29
Major  concerns  about  low birth  weight,  length,  and  pon-
deral  index  emerged  due  to  their  negative  effect  on  infant
health,  associated  with  higher  perinatal  mortality:  mechan-
ical  ventilation,  supplemental  oxygen support,  later  oral
feeding,  retinopathy,  bronchopulmonary  dysplasia,  pneu-
mothorax,  intraventricular  hemorrhage,  and  other  pediatric
complications.30 Moreover,  more  developmental  problems
were  identified  in low birth  weight  neonates,  including  prob-
lems  of  attention,  cognition,  and neuromotor  functioning,
and  increasing  the  risk  of  early  childhood  morbidity.30
Some  limitations  should  be  pointed  out.  The  voluntary
nature  of  the  participation  in the  study  may  have  lead  to
a  selection  bias. Mothers  who  agreed  to  participate  and
completed  all  moments  of  assessment  may  be  those  who
feel  more  satisfied  and  involved  with  the  pregnancy  expe-
rience.  However,  no  differences  were  found  between  the
participants  who  completed  and did  not complete  all the
moments  of  assessment.  A  higher  sample  size  might  increase
the  statistical  power  of  the analysis.  A standardized  clinical
interview  to  assess  depression  and anxiety  could  increase
the  validity  of  the  results.  However,  both  measures  showed
good  internal  consistency.  Unmeasured  confounding  factors
may have  influenced  the  effects  described.  However,  some
of  these  factors  (mother’s  weight  before  pregnancy,  tobacco
and  coffee  consumption  during  pregnancy)  were controlled
in  the  analysis.
This  study  demonstrates  the independent  longitudinal
effect  of  maternal  anxiety  on major  markers  of  fetal-
neonatal  growth  outcomes  and  trajectories,  simultaneously
considering  the effect  of maternal  depression  and  anxi-
ety.  This  highlights  an increased  necessity  of systematic
screening  for  anxiety  during  pregnancy.  These  findings  also
suggested  that  fetuses  of  anxious  mothers  are  those  who
might  benefit  from  individualized  care in  neonatal  care
units.
Suggestions  to  future  research  can  be  indicated.  Future
studies  could  simultaneously  explore  the independent
effects  of  both  maternal  depression  and  anxiety  on
other  markers  of  fetal-neonatal  growth,  behavior,  and
maturation.  Future research  could  also  explore  the medi-
ator  role  of epigenetic  and  endophenotypic  mechanisms  on
the  effect  of  maternal  prenatal  anxiety  on  fetal-neonatal
growth  outcomes  and  trajectories.
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